Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Psoriasis during natalizumab treatment for multiple sclerosis.
The impact of environmental infections (parasites) on MS activity.
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
[Vitamin D for prevention of diseases?].
Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis
Possible pathogenic engagement of soluble Semaphorin 4D produced by γδT cells in medication-related osteonecrosis of the jaw (MRONJ).
An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β.
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.
Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial.
Olive oil phenols and neuroprotection.
The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry.
Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study.
Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis.
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
Early pathological alterations of lower lumbar cords detected by ultrahigh-field MRI in a mouse multiple sclerosis model.
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
High risk of MS in Iranian immigrants in Gothenburg, Sweden.
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.

Pages